Unique IRT implementation considerations for personalised medicine trials

Treatments that are curated based on the individual’s characteristics (e.g., biological, cellular, or genomic) offer the potential to dramatically improve human health, and the number of Personalised or Precision Medicine Trials (PMTs) is growing. Much hinges on the design of the medication management tools within the IRT system, which must accommodate several specialised considerations. Such challenges can only be met with a uniquely flexible system and the counsel of experienced professionals who can foresee areas of risk and recommend innovative solutions.

Download our whitepaper today to learn how Almac Clinical Technologies can implement these design complexities on the IXRS®3 platform to ensure their successful execution from start to finish.